Brief: Lucid Diagnostics Announces Positive Data From Its ESOGUARD BE-1 Prospective, International, Multicenter Clinical Validation Study
02/07/2024 13:32
July 2 (Reuters) - Lucid Diagnostics Inc LUCD.O :
* LUCID DIAGNOSTICS ANNOUNCES POSITIVE DATA FROM ITS
ESOGUARD BE-1
PROSPECTIVE, INTERNATIONAL, MULTICENTER CLINICAL VALIDATION
STUDY OF ESOGUARD® ESOPHAGEAL PRECANCER TESTING IN A SCREENING
POPULATION
Source text for Eikon: ID:nPn3vCXL3a
Further company coverage: LUCD.O
((Reuters.Briefs@thomsonreuters.com;))